Cergentis news


Cergentis’ CEO invited to present TLA technology at ACTIP meeting in Dusseldorf

| |
1 min read

On June 7, our CEO attended the ACTIP meeting in Dusseldorf where he had the privilege of being invited to give a presentation, entitled: '’The Targeted Locus Amplification (TLA) technology and targeted complete Next Generation Sequencing of transgenes & integration sites in cell line development and quality control.'’

ACTIP - Animal Cell Technology Industrial Platform - is an independent forum of European companies interested in mammalian cell technology (animal cells, human cells, primary cells, insect cells and stem cells) for the development and production of biopharmaceuticals, vaccines and other preventatives or therapeutics.

© 2012-2022 Cergentis B.V. All rights reserved.
For Research Use Only. Not for use in diagnostic procedures.